マイトジェン活性化プロテインキナーゼ8
WordNet
- aerate (sewage) so as to favor the growth of organisms that decompose organic matter (同)aerate
- make (substances) radioactive
- make active or more active; "activate an old file"
- make more adsorptive; "activate a metal"
- rendered active; e.g. rendered radioactive or luminescent or photosensitive or conductive
- (of e.g. a molecule) made reactive or more reactive (同)excited
- (military) set up and placed on active assignment; "a newly activated unit"
- (of sewage) treated with aeration and bacteria to aid decomposition
- any of a large group of nitrogenous organic compounds that are essential constituents of living cells; consist of polymers of amino acids; essential in the diet of animals for growth and for repair of tissues; can be obtained from meat and eggs and milk and legumes; "a diet high in protein"
- an enzyme that catalyzes the conversion of a proenzyme to an active enzyme
- an agent that triggers mitosis
PrepTutorEJDIC
- …'を'活動的にする / …‘に'放射能を与える / 〈物質〉'を'活性化する
- 蛋白(たんばく)質
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2012/11/15 13:30:26」(JST)
[Wiki en表示]
Mitogen-activated protein kinase 8 |
PDB rendering based on 1jnk. |
Available structures |
PDB |
Ortholog search: PDBe, RCSB |
List of PDB id codes |
1UKH, 1UKI, 2G01, 2GMX, 2H96, 2NO3, 2XRW, 2XS0, 3ELJ, 3O17, 3O2M, 3PZE
|
|
|
Identifiers |
Symbols |
MAPK8; JNK; JNK-46; JNK1; JNK1A2; JNK21B1/2; PRKM8; SAPK1; SAPK1c |
External IDs |
OMIM: 601158 MGI: 1346861 HomoloGene: 56760 ChEMBL: 2276 GeneCards: MAPK8 Gene |
EC number |
2.7.11.24 |
Gene Ontology |
Molecular function |
• protein serine/threonine kinase activity
• JUN kinase activity
• protein binding
• ATP binding
• histone deacetylase regulator activity
• histone deacetylase binding
|
Cellular component |
• nucleus
• nucleoplasm
• cytosol
|
Biological process |
• toll-like receptor signaling pathway
• MyD88-dependent toll-like receptor signaling pathway
• MyD88-independent toll-like receptor signaling pathway
• apoptotic process
• response to stress
• JNK cascade
• JUN phosphorylation
• Toll signaling pathway
• induction of apoptosis by extracellular signals
• activation of pro-apoptotic gene products
• response to UV
• positive regulation of gene expression
• peptidyl-serine phosphorylation
• peptidyl-threonine phosphorylation
• regulation of histone deacetylation
• negative regulation of protein binding
• regulation of protein localization
• toll-like receptor 1 signaling pathway
• toll-like receptor 2 signaling pathway
• toll-like receptor 3 signaling pathway
• toll-like receptor 4 signaling pathway
• TRIF-dependent toll-like receptor signaling pathway
• negative regulation of apoptotic process
• innate immune response
• nerve growth factor receptor signaling pathway
• regulation of sequence-specific DNA binding transcription factor activity
• stress-activated MAPK cascade
• cellular response to mechanical stimulus
• positive regulation of deacetylase activity
|
Sources: Amigo / QuickGO |
|
RNA expression pattern |
|
|
More reference expression data |
Orthologs |
Species |
Human |
Mouse |
|
Entrez |
5599 |
26419 |
|
Ensembl |
ENSG00000107643 |
ENSMUSG00000021936 |
|
UniProt |
P45983 |
Q91Y86 |
|
RefSeq (mRNA) |
NM_002750.2 |
NM_016700.4 |
|
RefSeq (protein) |
NP_002741.1 |
NP_057909.1 |
|
Location (UCSC) |
Chr 10:
49.51 – 49.65 Mb |
Chr 14:
33.38 – 33.45 Mb |
|
PubMed search |
[1] |
[2] |
|
|
Mitogen-activated protein kinase 8 (also known as JNK1) is an enzyme that in humans is encoded by the MAPK8 gene.[1][2]
The protein encoded by this gene is a member of the MAP kinase and JNK family. MAP kinases act as an integration point for multiple biochemical signals, and are involved in a wide variety of cellular processes such as proliferation, differentiation, transcription regulation and development. This kinase is activated by various cell stimuli, and targets specific transcription factors, and thus mediates immediate-early gene expression in response to cell stimuli. The activation of this kinase by tumor-necrosis factor alpha (TNF-alpha) is found to be required for TNF-alpha-induced apoptosis. This kinase is also involved in UV radiation-induced apoptosis, which is thought to be related to the cytochrome c-mediated cell death pathway. Studies of the mouse counterpart of this gene suggested that this kinase play a key role in T cell proliferation, apoptosis and differentiation. Four alternately spliced transcript variants encoding distinct isoforms have been reported.[3]
Contents
- 1 Interactions
- 2 References
- 3 External links
- 4 Further reading
|
Interactions
MAPK8 has been shown to interact with SPIB,[4] DUSP1,[5] Activating transcription factor 2,[6][7][8][9] SH3BP5,[10] GSTP1,[11] MAPK8IP1,[12][13] MAP2K7,[9][14] CRK,[15] MAP2K4,[8][9][14][16][17] DUSP22,[18] Myc,[19] MAP3K2,[14] DUSP10,[20] REL,[21] MAPK8IP3,[22][23] IRS1,[24][25] MAP3K1[26] and C-jun.[1][9][21][27][28][29][30][31]
References
- ^ a b Derijard B, Hibi M, Wu IH, Barrett T, Su B, Deng T, Karin M, Davis RJ (April 1994). "JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain". Cell 76 (6): 1025–37. doi:10.1016/0092-8674(94)90380-8. PMID 8137421.
- ^ Gupta S, Barrett T, Whitmarsh AJ, Cavanagh J, Sluss HK, Derijard B, Davis RJ (July 1996). "Selective interaction of JNK protein kinase isoforms with transcription factors". EMBO J 15 (11): 2760–70. PMC 450211. PMID 8654373. //www.ncbi.nlm.nih.gov/pmc/articles/PMC450211/.
- ^ "Entrez Gene: MAPK8 mitogen-activated protein kinase 8". http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=5599.
- ^ Mao, C; Ray-Gallet D, Tavitian A, Moreau-Gachelin F (February 1996). "Differential phosphorylations of Spi-B and Spi-1 transcription factors". Oncogene (ENGLAND) 12 (4): 863–73. ISSN 0950-9232. PMID 8632909.
- ^ Slack, D N; Seternes O M, Gabrielsen M, Keyse S M (May. 2001). "Distinct binding determinants for ERK2/p38alpha and JNK map kinases mediate catalytic activation and substrate selectivity of map kinase phosphatase-1". J. Biol. Chem. (United States) 276 (19): 16491–500. doi:10.1074/jbc.M010966200. ISSN 0021-9258. PMID 11278799.
- ^ Raingeaud, J; Gupta S, Rogers J S, Dickens M, Han J, Ulevitch R J, Davis R J (March 1995). "Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine". J. Biol. Chem. (UNITED STATES) 270 (13): 7420–6. doi:10.1074/jbc.270.13.7420. ISSN 0021-9258. PMID 7535770.
- ^ Fuchs, S Y; Xie B, Adler V, Fried V A, Davis R J, Ronai Z (December 1997). "c-Jun NH2-terminal kinases target the ubiquitination of their associated transcription factors". J. Biol. Chem. (UNITED STATES) 272 (51): 32163–8. doi:10.1074/jbc.272.51.32163. ISSN 0021-9258. PMID 9405416.
- ^ a b Chen, Z; Cobb M H (May. 2001). "Regulation of stress-responsive mitogen-activated protein (MAP) kinase pathways by TAO2". J. Biol. Chem. (United States) 276 (19): 16070–5. doi:10.1074/jbc.M100681200. ISSN 0021-9258. PMID 11279118.
- ^ a b c d Tournier, C; Whitmarsh A J, Cavanagh J, Barrett T, Davis R J (July 1997). "Mitogen-activated protein kinase kinase 7 is an activator of the c-Jun NH2-terminal kinase". Proc. Natl. Acad. Sci. U.S.A. (UNITED STATES) 94 (14): 7337–42. doi:10.1073/pnas.94.14.7337. ISSN 0027-8424. PMC 23822. PMID 9207092. //www.ncbi.nlm.nih.gov/pmc/articles/PMC23822/.
- ^ Wiltshire, Carolyn; Matsushita Masato, Tsukada Satoshi, Gillespie David A F, May Gerhard H W (November 2002). "A new c-Jun N-terminal kinase (JNK)-interacting protein, Sab (SH3BP5), associates with mitochondria". Biochem. J. (England) 367 (Pt 3): 577–85. doi:10.1042/BJ20020553. ISSN 0264-6021. PMC 1222945. PMID 12167088. //www.ncbi.nlm.nih.gov/pmc/articles/PMC1222945/.
- ^ Wang, T; Arifoglu P, Ronai Z, Tew K D (June 2001). "Glutathione S-transferase P1-1 (GSTP1-1) inhibits c-Jun N-terminal kinase (JNK1) signaling through interaction with the C terminus". J. Biol. Chem. (United States) 276 (24): 20999–1003. doi:10.1074/jbc.M101355200. ISSN 0021-9258. PMID 11279197.
- ^ Whitmarsh, A J; Cavanagh J, Tournier C, Yasuda J, Davis R J (September 1998). "A mammalian scaffold complex that selectively mediates MAP kinase activation". Science (UNITED STATES) 281 (5383): 1671–4. doi:10.1126/science.281.5383.1671. ISSN 0036-8075. PMID 9767029.
- ^ Cai, Yi; Lechner Mark S, Nihalani Deepak, Prindle Marc J, Holzman Lawrence B, Dressler Gregory R (January 2002). "Phosphorylation of Pax2 by the c-Jun N-terminal kinase and enhanced Pax2-dependent transcription activation". J. Biol. Chem. (United States) 277 (2): 1217–22. doi:10.1074/jbc.M109663200. ISSN 0021-9258. PMID 11700324.
- ^ a b c Cheng, J; Yang J, Xia Y, Karin M, Su B (April 2000). "Synergistic Interaction of MEK Kinase 2, c-Jun N-Terminal Kinase (JNK) Kinase 2, and JNK1 Results in Efficient and Specific JNK1 Activation". Mol. Cell. Biol. (UNITED STATES) 20 (7): 2334–42. doi:10.1128/MCB.20.7.2334-2342.2000. ISSN 0270-7306. PMC 85399. PMID 10713157. //www.ncbi.nlm.nih.gov/pmc/articles/PMC85399/.
- ^ Girardin, S E; Yaniv M (July 2001). "A direct interaction between JNK1 and CrkII is critical for Rac1-induced JNK activation". EMBO J. (England) 20 (13): 3437–46. doi:10.1093/emboj/20.13.3437. ISSN 0261-4189. PMC 125507. PMID 11432831. //www.ncbi.nlm.nih.gov/pmc/articles/PMC125507/.
- ^ Lee, Clement M; Onésime Djamila, Reddy C Damodara, Dhanasekaran N, Reddy E Premkumar (October 2002). "JLP: A scaffolding protein that tethers JNK/p38MAPK signaling modules and transcription factors". Proc. Natl. Acad. Sci. U.S.A. (United States) 99 (22): 14189–94. doi:10.1073/pnas.232310199. ISSN 0027-8424. PMC 137859. PMID 12391307. //www.ncbi.nlm.nih.gov/pmc/articles/PMC137859/.
- ^ Park, Hee-Sae; Kim Mi-Sung, Huh Sung-Ho, Park Jihyun, Chung Jongkyeong, Kang Sang Sun, Choi Eui-Ju (January 2002). "Akt (protein kinase B) negatively regulates SEK1 by means of protein phosphorylation". J. Biol. Chem. (United States) 277 (4): 2573–8. doi:10.1074/jbc.M110299200. ISSN 0021-9258. PMID 11707464.
- ^ Aoyama, K; Nagata M, Oshima K, Matsuda T, Aoki N (July 2001). "Molecular cloning and characterization of a novel dual specificity phosphatase, LMW-DSP2, that lacks the cdc25 homology domain". J. Biol. Chem. (United States) 276 (29): 27575–83. doi:10.1074/jbc.M100408200. ISSN 0021-9258. PMID 11346645.
- ^ Noguchi, K; Kitanaka C, Yamana H, Kokubu A, Mochizuki T, Kuchino Y (November 1999). "Regulation of c-Myc through phosphorylation at Ser-62 and Ser-71 by c-Jun N-terminal kinase". J. Biol. Chem. (UNITED STATES) 274 (46): 32580–7. doi:10.1074/jbc.274.46.32580. ISSN 0021-9258. PMID 10551811.
- ^ Tanoue, T; Moriguchi T, Nishida E (July 1999). "Molecular cloning and characterization of a novel dual specificity phosphatase, MKP-5". J. Biol. Chem. (UNITED STATES) 274 (28): 19949–56. doi:10.1074/jbc.274.28.19949. ISSN 0021-9258. PMID 10391943.
- ^ a b Meyer, C F; Wang X, Chang C, Templeton D, Tan T H (April 1996). "Interaction between c-Rel and the mitogen-activated protein kinase kinase kinase 1 signaling cascade in mediating kappaB enhancer activation". J. Biol. Chem. (UNITED STATES) 271 (15): 8971–6. doi:10.1074/jbc.271.15.8971. ISSN 0021-9258. PMID 8621542.
- ^ Ito, M; Yoshioka K, Akechi M, Yamashita S, Takamatsu N, Sugiyama K, Hibi M, Nakabeppu Y, Shiba T, Yamamoto K I (November 1999). "JSAP1, a Novel June N-Terminal Protein Kinase (JNK)-Binding Protein That Functions as a Scaffold Factor in the JNK Signaling Pathway". Mol. Cell. Biol. (UNITED STATES) 19 (11): 7539–48. ISSN 0270-7306. PMC 84763. PMID 10523642. //www.ncbi.nlm.nih.gov/pmc/articles/PMC84763/.
- ^ Kelkar, N; Gupta S, Dickens M, Davis R J (February 2000). "Interaction of a Mitogen-Activated Protein Kinase Signaling Module with the Neuronal Protein JIP3". Mol. Cell. Biol. (UNITED STATES) 20 (3): 1030–43. doi:10.1128/MCB.20.3.1030-1043.2000. ISSN 0270-7306. PMC 85220. PMID 10629060. //www.ncbi.nlm.nih.gov/pmc/articles/PMC85220/.
- ^ Aguirre, Vincent; Werner Eric D, Giraud Jodel, Lee Yong Hee, Shoelson Steve E, White Morris F (January 2002). "Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action". J. Biol. Chem. (United States) 277 (2): 1531–7. doi:10.1074/jbc.M101521200. ISSN 0021-9258. PMID 11606564.
- ^ Aguirre, V; Uchida T, Yenush L, Davis R, White M F (March 2000). "The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307)". J. Biol. Chem. (UNITED STATES) 275 (12): 9047–54. doi:10.1074/jbc.275.12.9047. ISSN 0021-9258. PMID 10722755.
- ^ Xu, S; Cobb M H (December 1997). "MEKK1 binds directly to the c-Jun N-terminal kinases/stress-activated protein kinases". J. Biol. Chem. (UNITED STATES) 272 (51): 32056–60. doi:10.1074/jbc.272.51.32056. ISSN 0021-9258. PMID 9405400.
- ^ Ishitani, Tohru; Takaesu Giichi, Ninomiya-Tsuji Jun, Shibuya Hiroshi, Gaynor Richard B, Matsumoto Kunihiro (December 2003). "Role of the TAB2-related protein TAB3 in IL-1 and TNF signaling". EMBO J. (England) 22 (23): 6277–88. doi:10.1093/emboj/cdg605. ISSN 0261-4189. PMC 291846. PMID 14633987. //www.ncbi.nlm.nih.gov/pmc/articles/PMC291846/.
- ^ Nishitoh, H; Saitoh M, Mochida Y, Takeda K, Nakano H, Rothe M, Miyazono K, Ichijo H (September 1998). "ASK1 is essential for JNK/SAPK activation by TRAF2". Mol. Cell (UNITED STATES) 2 (3): 389–95. doi:10.1016/S1097-2765(00)80283-X. ISSN 1097-2765. PMID 9774977.
- ^ Yazgan, Oya; Pfarr Curt M (August 2002). "Regulation of two JunD isoforms by June N-terminal kinases". J. Biol. Chem. (United States) 277 (33): 29710–8. doi:10.1074/jbc.M204552200. ISSN 0021-9258. PMID 12052834.
- ^ Tada, K; Okazaki T, Sakon S, Kobarai T, Kurosawa K, Yamaoka S, Hashimoto H, Mak T W, Yagita H, Okumura K, Yeh W C, Nakano H (September 2001). "Critical roles of TRAF2 and TRAF5 in tumor necrosis factor-induced NF-kappa B activation and protection from cell death". J. Biol. Chem. (United States) 276 (39): 36530–4. doi:10.1074/jbc.M104837200. ISSN 0021-9258. PMID 11479302.
- ^ Cano, E; Hazzalin C A, Kardalinou E, Buckle R S, Mahadevan L C (November 1995). "Neither ERK nor JNK/SAPK MAP kinase subtypes are essential for histone H3/HMG-14 phosphorylation or c-fos and c-jun induction". J. Cell. Sci. (ENGLAND) 108 (11): 3599–609. ISSN 0021-9533. PMID 8586671.
External links
Further reading
- Davis RJ (2000). "Signal transduction by the JNK group of MAP kinases". Cell 103 (2): 239–52. doi:10.1016/S0092-8674(00)00116-1. PMID 11057897.
- Liu J, Lin A (2007). "Wiring the cell signaling circuitry by the NF-kappa B and JNK1 crosstalk and its applications in human diseases". Oncogene 26 (22): 3267–78. doi:10.1038/sj.onc.1210417. PMID 17496921.
This article incorporates text from the United States National Library of Medicine, which is in the public domain.
PDB gallery
|
|
|
1jnk: THE C-JUN N-TERMINAL KINASE (JNK3S) COMPLEXED WITH MGAMP-PNP
|
|
1pmn: Crystal structure of JNK3 in complex with an imidazole-pyrimidine inhibitor
|
|
1pmq: The structure of JNK3 in complex with an imidazole-pyrimidine inhibitor
|
|
1pmu: The crystal structure of JNK3 in complex with a phenantroline inhibitor
|
|
1pmv: The structure of JNK3 in complex with a dihydroanthrapyrazole inhibitor
|
|
1ukh: Structural basis for the selective inhibition of JNK1 by the scaffolding protein JIP1 and SP600125
|
|
1uki: Structural basis for the selective inhibition of JNK1 by the scaffolding protein JIP1 and SP600125
|
|
2b1p: inhibitor complex of JNK3
|
|
2exc: Inhibitor complex of JNK3
|
|
2g01: Pyrazoloquinolones as Novel, Selective JNK1 inhibitors
|
|
2gmx: Selective Aminopyridine-Based C-Jun N-terminal Kinase inhibitors with cellular activity
|
|
2h96: Discovery of Potent, Highly Selective, and Orally Bioavailable Pyridine Carboxamide C-jun NH2-terminal Kinase Inhibitors
|
|
2no3: Novel 4-anilinopyrimidines as potent JNK1 Inhibitors
|
|
2o0u: Crystal structure of human JNK3 complexed with N-{3-cyano-6-[3-(1-piperidinyl)propanoyl]-4,5,6,7-tetrahydrothieno[2,3-c]pyridin-2-yl}-1-naphthalenecarboxamide
|
|
2o2u: Crystal structure of human JNK3 complexed with N-(3-cyano-4,5,6,7-tetrahydro-1-benzothien-2-yl)-2-fluorobenzamide
|
|
2ok1: Crystal structure of JNK3 bound to N-benzyl-4-(4-(3-chlorophenyl)-1H-pyrazol-3-yl)-1H-pyrrole-2-carboxamide
|
|
|
|
Kinases: Serine/threonine-specific protein kinases (EC 2.7.11-12)
|
|
Serine/threonine-specific protein kinases (EC 2.7.11.1-EC 2.7.11.20)
|
|
|
|
|
Serine/threonine-specific protein kinases (EC 2.7.11.21-EC 2.7.11.30)
|
|
Polo kinase (EC 2.7.11.21) |
|
|
Cyclin-dependent kinase (EC 2.7.11.22) |
- CDK1
- CDK2
- CDKL2
- CDK3
- CDK4
- CDK5
- CDKL5
- CDK6
- CDK7
- CDK8
- CDK9
- CDK10
- CDC2L5
- CRKRS
- PCTK1
- PCTK2
- PCTK3
- PFTK1
- CDC2L1
|
|
(RNA-polymerase)-subunit kinase (EC 2.7.11.23) |
- RPS6KA5
- RPS6KA4
- P70S6 kinase
- P70-S6 Kinase 1
- RPS6KB2
- RPS6KA2
- RPS6KA3
- RPS6KA1
- RPS6KC1
|
|
Mitogen-activated protein kinase (EC 2.7.11.24) |
- Extracellular signal-regulated
- MAPK1
- MAPK3
- MAPK4
- MAPK6
- MAPK7
- MAPK12
- MAPK15
- C-Jun N-terminal
- P38 mitogen-activated protein
|
|
MAP3K (EC 2.7.11.25) |
- MAP kinase kinase kinases
- MAP3K1
- MAP3K2
- MAP3K3
- MAP3K4
- MAP3K5
- MAP3K6
- MAP3K7
- MAP3K8
- RAFs
- MLKs
- MAP3K12
- MAP3K13
- MAP3K9
- MAP3K10
- MAP3K11
- MAP3K7
- ZAK
- CDC7
- MAP3K14
|
|
Tau-protein kinase (EC 2.7.11.26) |
|
|
(acetyl-CoA carboxylase) kinase (EC 2.7.11.27) |
-
|
|
Tropomyosin kinase (EC 2.7.11.28) |
-
|
|
Low-density-lipoprotein receptor kinase (EC 2.7.11.29) |
-
|
|
Receptor protein serine/threonine kinase (EC 2.7.11.30) |
- Bone morphogenetic protein receptors
- BMPR1
- BMPR1A
- BMPR1B
- BMPR2
- ACVR1
- ACVR1B
- ACVR1C
- ACVR2A
- ACVR2B
- ACVRL1
- Anti-Müllerian hormone receptor
|
|
|
|
Dual-specificity kinases (EC 2.7.12)
|
|
MAP2K |
- MAP2K1
- MAP2K2
- MAP2K3
- MAP2K4
- MAP2K5
- MAP2K6
- MAP2K7
|
|
|
|
- B
- enzm
- 1.1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 10
- 11
- 13
- 14
- 15-18
- 2.1
- 2.7.10
- 2.7.11-12
- 3.1
- 4.1
- 5.1
- 6.1-3
|
|
|
|
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Involvement of autophagy induction in penta-1,2,3,4,6-O-galloyl-β-D-glucose-induced senescence-like growth arrest in human cancer cells.
- Dong Y1, Yin S2, Jiang C3, Luo X4, Guo X2, Zhao C2, Fan L5, Meng Y6, Lu J3, Song X2, Zhang X2, Chen N2, Hu H2.Author information 1Department of Nutrition and Health; College of Food Science and Nutritional Engineering; Beijing Key Laboratory of Functional Food from Plant Resources; China Agricultural University; Beijing, China; Department of Biomedical Sciences; Texas Tech University School of Pharmacy; Amarillo, TX USA.2Department of Nutrition and Health; College of Food Science and Nutritional Engineering; Beijing Key Laboratory of Functional Food from Plant Resources; China Agricultural University; Beijing, China.3Department of Biomedical Sciences; Texas Tech University School of Pharmacy; Amarillo, TX USA.4Department of Hepatobiliary Surgery; The First Affiliated Hospital; Harbin Medical University; Harbin, Heilongjiang China.5College of Veterinary Medicine; China Agricultural University; Beijing, China.6Nanyang Administration of Traditional Chinese Medicine; Nanyang, Henan China.AbstractGrowing evidence has demonstrated that autophagy plays important and paradoxical roles in carcinogenesis, while senescence is considered to be a crucial tumor-suppressor mechanism in cancer prevention and treatment. In the present study we demonstrated that both autophagy and senescence were induced in response to penta-1,2,3,4,6-O-galloyl-β-D-glucose (PGG), a chemopreventive polyphonolic compound, in multiple types of cancer cells. Analysis of these 2 events over the experimental time course indicated that autophagy and senescence occurred in parallel early in the process and dissociated later. The long-term culture study suggested that a subpopulation of senescent cells may have the capacity to reenter the cell cycle. Inhibition of autophagy by either a chemical inhibitor or RNA interference led to a significant reduction of PGG-induced senescence, followed by induction of apoptosis. These results suggested that autophagy promoted senescence induction by PGG and that PGG might exert its anticancer activity through autophagy-mediated senescence. For the first time, these findings uncovered the relationships among autophagy, senescence, and apoptosis induced by PGG. In addition, we identified that unfolded protein response signaling played a pivotal role in the autophagy-mediated senescence phenotype. Furthermore, our data showed that activation of MAPK8/9/10 (mitogen-activated protein kinase 8/9/10/c-Jun N-terminal kinases) was an essential upstream signal for PGG-induced autophagy. Finally, the key in vitro results were validated in vivo in a xenograft mouse model of human HepG2 liver cancer. Our findings provided novel insights into understanding the mechanisms and functions of PGG-induced autophagy and senescence in human cancer cells.
- Autophagy.Autophagy.2014 Feb;10(2):296-310. doi: 10.4161/auto.27210. Epub 2013 Dec 18.
- Growing evidence has demonstrated that autophagy plays important and paradoxical roles in carcinogenesis, while senescence is considered to be a crucial tumor-suppressor mechanism in cancer prevention and treatment. In the present study we demonstrated that both autophagy and senescence were induced
- PMID 24389959
- Intracellular mobility and nuclear trafficking of the stress-activated kinase JNK1 are impeded by hyperosmotic stress.
- Misheva M1, Kaur G2, Ngoei KR1, Yeap YY1, Ng IH3, Wagstaff KM4, Ng DC1, Jans DA4, Bogoyevitch MA5.Author information 1Department of Biochemistry and Molecular Biology, Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Victoria 3010, Australia.2Department of Biochemistry and Molecular Biology, Monash University, Victoria 3800, Australia; European Molecular Biology Laboratory (EMBL) Australia, Australian Regenerative Medicine Institute, Monash University, Clayton, Victoria 3800, Australia.3Department of Biochemistry and Molecular Biology, Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Victoria 3010, Australia; Department of Biochemistry and Molecular Biology, Monash University, Victoria 3800, Australia.4Department of Biochemistry and Molecular Biology, Monash University, Victoria 3800, Australia.5Department of Biochemistry and Molecular Biology, Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Victoria 3010, Australia. Electronic address: marieb@unimelb.edu.au.AbstractThe c-Jun N-terminal kinases (JNKs) are a group of stress-activated protein kinases that regulate gene expression changes through specific phosphorylation of nuclear transcription factor substrates. To address the mechanisms underlying JNK nuclear entry, we employed a semi-intact cell system to demonstrate for the first time that JNK1 nuclear entry is dependent on the importin α2/β1 heterodimer and independent of importins α3, α4, β2, β3, 7 and 13. However, quantitative image analysis of JNK1 localization following exposure of cells to either arsenite or hyperosmotic stress did not indicate its nuclear accumulation. Extending our analyses to define the dynamics of nuclear trafficking of JNK1, we combined live cell imaging analyses with fluorescence recovery after photobleaching (FRAP) protocols. Subnuclear and subcytoplasmic bleaching protocols revealed the slowed movement of JNK1 in both regions in response to hyperosmotic stress. Strikingly, while movement into the nucleus of green fluorescent protein (GFP) or transport of a GFP-T-antigen fusion protein as estimated by initial rates and time to reach half-maximal recovery (t1/2) measures remained unaltered, hyperosmotic stress slowed the nuclear entry of GFP-JNK1. In contrast, arsenite exposure which did not alter the initial rates of nuclear accumulation of GFP, GFP-T-antigen or GFP-JNK1, decreased the t1/2 for nuclear accumulation of both GFP and GFP-JNK1. Thus, our results challenge the paradigm of increased nuclear localization of JNK broadly in response to all forms of stress-activation and are consistent with enhanced interactions of stress-activated JNK1 with scaffold and substrate proteins throughout the nucleus and the cytosol under conditions of hyperosmotic stress.
- Biochimica et biophysica acta.Biochim Biophys Acta.2014 Feb;1843(2):253-64. doi: 10.1016/j.bbamcr.2013.10.017. Epub 2013 Nov 1.
- The c-Jun N-terminal kinases (JNKs) are a group of stress-activated protein kinases that regulate gene expression changes through specific phosphorylation of nuclear transcription factor substrates. To address the mechanisms underlying JNK nuclear entry, we employed a semi-intact cell system to demo
- PMID 24184208
- Natural feed contaminant zearalenone decreases the expressions of important pro- and anti-inflammatory mediators and mitogen-activated protein kinase/NF-κB signalling molecules in pigs.
- Pistol GC1, Gras MA1, Marin DE1, Israel-Roming F2, Stancu M1, Taranu I1.Author information 1Laboratory of Animal Biology, National Institute for Research and Development for Biology and Animal Nutrition, Calea Bucuresti No. 1, Balotesti, Ilfov 077015, Romania.2Biotechnology Department, University of Agriculture and Veterinary Medicine, Bulevardul Marasti No. 59, Bucharest 011464, Romania.AbstractZearalenone (ZEA) is an oestrogenic mycotoxin produced by Fusarium species, considered to be a risk factor from both public health and agricultural perspectives. In the present in vivo study, a feeding trial was conducted to evaluate the in vivo effect of a ZEA-contaminated diet on immune response in young pigs. The effect of ZEA on pro-inflammatory (TNF-α, IL-8, IL-6, IL-1β and interferon-γ) and anti-inflammatory (IL-10 and IL-4) cytokines and other molecules involved in inflammatory processes (matrix metalloproteinases (MMP)/tissue inhibitors of matrix metalloproteinases (TIMP), nuclear receptors: PPARγ and NF-κB1, mitogen-activated protein kinases (MAPK): mitogen-activated protein kinase kinase kinase 7 (TAK1)/mitogen-activated protein kinase 14 (p38α)/mitogen-activated protein kinase 8 (JNK1)/ mitogen-activated protein kinase 9 (JNK2)) in the liver of piglets was investigated. The present results showed that a concentration of 316 parts per billion ZEA leads to a significant decrease in the levels of pro- and anti-inflammatory cytokines at both gene expression and protein levels, correlated with a decrease in the levels of other inflammatory mediators, MMP and TIMP. The results also showed that dietary ZEA induces a dramatic reduction in the expressions of NF-κB1 and TAK1/p38α MAPK genes in the liver of the experimentally intoxicated piglets, and has no effect on the expression of PPARγ mRNA. The present results suggest that the toxic action of ZEA begins in the upstream of the MAPK signalling pathway by the inhibition of TAK1, a MAPK/NF-κB activator. In conclusion, the present study shows that ZEA alters several important parameters of the hepatic cellular immune response. From an economic point of view, these data suggest that, in pigs, ZEA is not only a powerful oestrogenic mycotoxin but also a potential hepatotoxin when administered through the oral route. Therefore, the present results represent additional data from cellular and molecular levels that could be taken into account in the determination of the regulation limit of the tolerance to ZEA.
- The British journal of nutrition.Br J Nutr.2014 Feb;111(3):452-64. doi: 10.1017/S0007114513002675. Epub 2013 Aug 20.
- Zearalenone (ZEA) is an oestrogenic mycotoxin produced by Fusarium species, considered to be a risk factor from both public health and agricultural perspectives. In the present in vivo study, a feeding trial was conducted to evaluate the in vivo effect of a ZEA-contaminated diet on immune response i
- PMID 23962703
Japanese Journal
- ROS Are Required for Mouse Spermatogonial Stem Cell Self-Renewal
- Morimoto Hiroko,Iwata Kazumi,Ogonuki Narumi,Inoue Kimiko,Ogura Atsuo,Kanatsu-Shinohara Mito,Morimoto Takeshi,Yabe-Nishimura Chihiro,Shinohara Takashi
- Cell Stem Cell 12(6), 774-786, 2013-06-00
- … SSCs depleted of ROS stopped proliferating, but they showed enhanced self-renewal when ROS levels were increased by the addition of hydrogen peroxide, which induced the phosphorylation of stress kinases p38 mitogen-activated protein kinase (MAPK) and c-jun N-terminal kinase (JNK). …
- NAID 120005285490
- Roles of FGF20 in dopaminergic neurons and Parkinson's disease.
- Itoh Nobuyuki,Ohta Hiroya
- Frontiers in molecular neuroscience 6, 2013-05-00
- … Fgf20, which acts on proximal cells, significantly enhanced the survival of cultured dopaminergic neurons by activating the mitogen-activated protein kinase (MAPK) pathway through Fgf receptor 1c. …
- NAID 120005289845
- Central role of the exchange factor GEF-H1 in TNF-α–induced sequential activation of Rac, ADAM17/TACE, and RhoA in tubular epithelial cells
- Waheed Faiza,Dan Qinghong,Amoozadeh Yasaman,Zhang Yuqian,Tanimura Susumu,Speight Pam,Kapus András,Szászi Katalin
- Molecular Biology of the Cell 24(7), 1068-1082, 2013-04-01
- … TACE activation requires the mitogen-activated protein kinase p38, which is activated through the small GTPase Rac. …
- NAID 120005231330
Related Links
- GoPubMed lists recent and important papers and reviews for mitogen-activated protein kinase 8(JNK) ... In the present paper, the authors summarize mechanisms of acupuncture for depression from 1) upregulating levels of ...
- Search Blast * Align * Retrieve ID Mapping * Search in Query Advanced Search » Show advanced search options Reset button Search Blast * Align * Retrieve ID Mapping * Sequence or UniProt identifier Blast Clear « Options
Related Pictures
★リンクテーブル★
[★]
- 英
- mitogen-activated protein kinase 8
[★]
- 関
- activate、activated form、activation、turn on
[★]
- 関
- activated、activation、turn on
[★]
キナーゼ カイネース リン酸化酵素 phosphoenzyme phosphotransferase
[★]
プロテインキナーゼ
- 同
- protein kinases